Summary
The differential diagnosis between Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes is complicated since no specific markers are available for either disease. In this study, 244 consecutive patients were diagnosed with diabetes mellitus during two years in Malmö (230000 inhabitants), corresponding to an incidence rate of 53·100000−1·year−1. Age, body mass index, HbA1c, C-peptide, and levels of islet cell antibodies were determined at the clinical onset, and related to the classification at diagnosis and at follow-up (n=233) after a median time of 31 (range 1–49) months. After diagnosis, 42 of 244 (17%) were started on insulin while 202 of 244 (83%) were not. Islet cell antibodies were present in 25 of 42 (60%), and in 18 of 183 (10%), respectively. In the non-insulin treated group, patients with islet cell antibodies had lower body mass index (p<0.001), higher HbA1c (p<0.004), and lower C-peptide (p<0.001) than patients without. At follow-up, 11 of 18 (61%) islet cell positive patients were changed to insulin treatment, as were six other patients. Insulin was discontinued in five initially insulin-treated but islet cell antibody negative patients. The sensitivity, specificity and predictive value for insulin treatment at follow-up were for islet cell antibody positivity; 72%, 96% and 84%, respectively, and for low C-peptide value; 60%, 96%, and 80%, respectively. Islet cell antibodies and low C-peptide at diagnosis of diabetes mellitus are concluded to be useful markers to predict insulin dependence.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gale EAM, Dornan TL, Tattersall RB (1981) Severely uncontrolled diabetes in the over-fifties. Diabetologia 21: 25–28
Grant PJ, Barlow E, Miles DW (1984) Plasma C-peptide levels identify insulin-treated patients suitable for oral hypoglycaemic therapy. Diab Med 1: 284–286
Stout RW (1979) Diabetes and atherosclerosis — the role of insulin. Diabetologia 16: 141–150
Madsbad S, Krarup T, McNair P, Christiansen C, Faber OK, Transböl I, Binder C (1981) Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 210: 153–156
Irvine WJ, Sawers JSA, Feek CM, Prescott RJ, Duncanc JP (1979) The value of islet cell antibody in predicting secondary failure of oral hypoglycemic agent therapy in diabetes mellitus. J Clin Immunol 2: 23–26
Gleichmann H, Zörcher B, Greulich B, Gries FA, Henrichs HR, Bertrams J, Kolb H (1984) Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia 27: 90–92
Wilson RM, Van der Minne P, Deverill I, Heller SR, Gelsthorpe K, Reeves WG, Tattersall RB (1985) Insulin dependence: problems with the classification of 100 consecutive patients. Diab Med 2: 167–172
Koskinen P, Viikari J, Irjala K, Kaihola H, Seepälä P (1986) Plasma and urinary C-peptide in the classification of adult diabetes. Scand J Clin Lab Invest 46: 655–663
Groop LC, Bottazzo GF, Doniach D (1986) Islet cell antibodies identify latent type 1 diabetes in patients aged 35–75 years at diagnosis. Diabetes 35: 237–241
WHO Study Group (1985) Report of diabetes mellitus technical report series No 727. WHO, Geneva
Jeppsson J, Jerntorp P, Sundkvist G, Englund H, Nylund V (1986) Measurement of hemoglobin A1c by a new liquid-chromatographic assay: Metodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32: 1867–1872
Heding LS (1975) Radioimmunological determination of C-peptide in serum. Diabetologia 11: 541–548
Kajinuma H, Tanabashi S, Ishiwata K, Kuzuya N (1979) Urinary excretion of C-peptide in relation to renal function. In: Baba S, Koneko T, Yanihara N (eds) Pro-insulin, insulin, and C-peptide. Excerpta Media, Amsterdam-Oxford, pp 183–189
Landin-Olsson M, Sundkvist G, Lernmark Å (1987) Prolonged incubation on the two-colour immunofluorescent test increases the prevalence and titres of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 327–332
Bonifacio E, Lernmark Å, Dawkins RL and co-authors (1988) Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 106: 83–88
Dahlquist G, Blom L, Tuvemo T, Nyström L, Sandström A, Wall S (1989) The Swedish childhood diabetes study — Results from a nine year case register and a one year case-referent study indicating that Type 1 (insulin-dependent) diabetes mellitus is associated with both Type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 32: 2–6
Östman J, Arnqvist H, Blohmé G, Lithner F, Littorin B, Nyström L, Sandström A, Scherstén B, Wall S, Wibell L (1986) Epidemiology of diabetes mellitus in Sweden. Results of the first year of a prospective study in the population age group 15–34 years. Acta Med Scand 220: 437–445
Uvstedt HJ, Olsen E (1977) Incidence of diabetes mellitus in Oslo, Norway. Br J Prev Soc Med 31: 251–257
Laakso M, Pyörälä K (1985) Age of onset and type of diabetes. Diabetes Care 8: 114–117
Gottlieb MS (1979) Diabetes in offspring and siblings of juvenile and maturity-onset-diabetics. J Chronic Dis 33: 331–339
Katzeff HL, Savage PJ, Barclay-White B, Nagulesparan M, Bennet PH (1985) C-peptide measurement in the differentiation of Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 28: 264–268
Nielsen NV, Tronier B (1987) C-peptide and insulin secretion in diabetes mellitus treated with oral hypoglycemic agents or diet alone. A 3 years epidemiological cohort study on the island of Falster, Denmark. Diabetes Research 4: 135–139
Faber OK, Binder C (1977) C-peptide response to glucagon. A test for the residual B-cell function in diabetes mellitus. Diabetes 26: 605–610
Horwitz DL, Starr JJ, Mako ME, Blackard W, Rubenstein AH (1975) Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55: 1278–1283
Gjessing HJ, Matzen LE, Fröland A, Faber OK (1987) Correlations between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics. Diabetes Care 10: 487–490
Kobayashi T, Sugimoto T, Itoh T, Kosaka K, Tanaka T, Suwa S, Sato K, Tsuji K (1986) The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method. Diabetes 35: 335–340
Groop L, Miettinen A, Groop P, Meri S, Koskimies S, Bottazzo GF (1988) Organ-specific autoimmunity and HLA-DR antigens as markers for β-cell destruction in patients with type II diabetes. Diabetes 37: 99–103
Di Mario U, Irvine WJ, Borsey DQ, Kyner JL, Weston J, Galfo C (1983) Immune abnormalities in diabetic patients not requiring insulin at diagnosis. Diabetologia 25: 392–395
Kilvert A, Fitzgerald MG, Wright AD, Nattrass M (1986) Clinical characteristics and aetiological classification of insulin-dependent diabetes in the elderly. Quart J Med, New Series 60: 865–872
Nordén G, Jensen E, Stilbo I, Bottazzo GF, Lernmark Å (1983) B-cell function and islet cell and other organ-specific autoantibodies in relatives to insulin-dependent diabetic patients. Acta Med Scand 213: 199–203
Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS (1985) First-degree relatives of patients with Type 1 diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med 313: 462–464
Tarn AC, Thomas JN, Dean BM, Ingram D, Schwarz G, Bottazzo GF, Gale EAM (1988) Predicting insulin-dependent diabetes. Lancet I: 845–850
Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark Å, Sundkvist G (1989) Islet cell and other organ-specific autoantibodies in all children developing Type 1 (insulin-independent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32: 387–395
Marner B, Agner T, Binder C, Lernmark Å, Nerup J, Mandrup-Poulsen T, Walldorff S (1985) Increased reduction in fasting C-peptide is associated with islet cell antibodies in Type 1 (insulindependent) diabetic patients. Diabetologia 28: 875–880
Tarn AC, Smith CP, Spencer KM, Bottazzo GF, Gale EAM (1987) Type 1 (insulin-dependent) diabetes: a disease of slow clinical onset? Br Med J 294: 342–345
Kolb H, Dannehl K, Grüneklee D, Zielasek J, Bertrams J, Hübinger A, Gries FA (1988) Prospective analysis of islet cell antibodies in children with Type 1 (insulin-dependent) diabetes. Diabetologia 31: 189–194
Landin-Olsson M, Sundkvist G, Lernmark Å, Nyström L, Arnqvist H, Blohmé G, Lithner F, Littorin B, Schersten B, Wibell L, Östman J (1989) Islet cell antibodies in relation to the type of diabetes at the clinical diagnosis in 464 recent onset 15–34 years old diabetic patients. Diabetologia 32: 508 Abstract
Karjalainen J, Salmela P, Ilonen J, Surcel H, Knip M (1989) A comparison of childhood and adult Type 1 diabetes mellitus. N Engl J Med 320: 881–886
Michelsen B, Lernmark Å (1987) Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest 79: 1144–1152
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paguette TL (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339
Drell DW, Notkins AL (1987) Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 132–143
Bækkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature (Lond) 298: 167–169
Kämpe O, Andersson A, Björk E, Hallberg A, Karlsson FA (1989) High-glucose simulation of 64000-Mr islet cell autoantigen expression. Diabetes 38: 1326–1328
Gotfredsen CF, Buschard K, Frandsen EK (1985) Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28: 933–935
Atkinson MA, Maclaren NK, Luchetta R, Burr I (1989) Prophylactic insulin therapy prevents insulitis and insulin dependent diabetes (IDD) in NOD mice. Diabetes 38 [Suppl 2]: 87 Abstract
Mirouze J, Selam JL, Pham TC, Mendoza E, Orsetti A (1978) Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas. Diabetologia 14: 223–227
Shah SC, Malone JI, Simpson NE (1989) A randomized trail of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med 320: 550–554
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Landin-Olsson, M., Nilsson, K.O., Lernmark, Å. et al. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 33, 561–568 (1990). https://doi.org/10.1007/BF00404145
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00404145